Although similarly high rates of CIN were observed in BRAF mutant and wild type MSS cancers, differences existed between the two cohorts regarding the chromosomal regions most commonly targeted, and the stages of presentation at which CIN was most frequent. The gene discussed is BRAF; the disease is cancer.